Apart from myasthenia Gravis, on which data on CRP are limited, and polymyositis, in which CRP can be elevated but still with no clinical utility in being a single biomarker, CRP can be an indicator of disease activity, and persistent elevated values may predict amyloidosis in juvenile chronic arthritis. The gene discussed is CRP; the disease is amyloidosis.